Latest News

A recent study revealed the factors determining carer burden lay not in the severity of dementia among sufferers, but instead on caregivers' feelings about themselves. [read more]

QIMR has developed a unique program for Indigenous and non-Indigenous high school students from across Queensland that gives them a greater insight into what happens 'in the lab' and to learn more about Indigenous health. [read more]

Researchers are giving smokers a very good reason to quit, following results of a study that found the longer people had stopped smoking, the better their chances of avoiding oesophageal cancer regardless of how long and how much they smoked. [read more]

Melanoma, the deadliest form of skin cancer, has long been known to be caused by sun exposure but some people are more likely to develop it than others. Researchers from QIMR and The Translational Genomic Research Institute in the US are close to discovering a new gene that could help explain variation in melanoma risk. [read more]

QIMR and Cancer Therapeutics (CTx) recently announced a collaboration to discover and develop new drugs for the treatment of many forms of cancer, based on hSSB1, a central protein required to protect humans from cancer-causing DNA damage. [read more]

A new treatment for coeliac disease, which affects one in every 100 Australians, could be on its way if clinical trials being conducted by Australian researchers prove effective. [read more]

Many women with a faulty breast cancer gene could be at greater risk of the disease due to extra 'risk amplifying' genes, according to research to be published in the American Journal of Human Genetics on 20 March 2008. [read more]

Australian scientists have discovered a new compound that reduces malaria parasite burden by up to 92 percent, opening a new avenue for anti-malarial drug development. [read more]

The Queensland Institute of Medical Research is calling for volunteers to take part in Phase 1 clinical trials for a new vaccine against malaria. [read more]

Obese people are six times as likely to develop gullet (oesophageal) cancer as people of 'healthy' weight, shows research conducted by the Queensland Institute of Medical Research and published ahead of print in the journal Gut. [read more]

The Queensland Institute of Medical Research (QIMR) and Merck & Co., Inc., a global pharmaceutical company, have entered into a research collaboration to develop a vaccine to combat Group A Streptococcus (GAS). [read more]

Scientists at QIMR have commenced Queensland's first population-based study into the causes of Crohn's disease and ulcerative colitis, disorders that affect up to one in every 200 Australians. [read more]

Scientists at QIMR have commenced Australia's first study into the causes of pancreatic cancer, the fourth most common cause of cancer death in Western Countries. [read more]

The Sit Down Comedy Company proudly presents a gala event dedicated to defeating depression through raising vital funding for QIMR's new world-class Mental Health Division. [read more]

An international collaborative research group has confirmed a common gene variant associated with breast cancer that actually reduces the risk of disease by up to 10 percent. [read more]

An Australian-first study aimed at preventing women from developing endometrial cancer is facing a road-block, and leading cancer experts are pointing the finger at a drop in the number of healthy Australians who are willing to take part in medical research studies. [read more]